诺和诺德（中国）制药有限公司

Novo Nordisk in China
As the leader in the Chinese market, Novo Nordisk has always been committed to change. Novo Nordisk (China) Pharmaceutical Co., Ltd. was established in 1994 and has maintained robust growth for over two decades. Headquartered in Beijing, the company provides products and services across all provinces, municipalities, and regions of China including Hong Kong, Macau, and *** . By the end of 2017, Novo Nordisk had a total of 4,329 employees in China. Novo Nordisk is a biopharmaceutical company that has established a research and development center in China. The R&D center in Beijing is part of Novo Nordisk's global R&D network, focusing on collaborating with headquarters to develop new products and production processes. The production facility in Tianjin, China, serves as an international strategic base for the company. The company has invested substantial funds and technical support into the factory, supplying products to both global and Chinese markets. The continuous development of Novo Nordisk in China reflects the company's commitment to the Chinese market.